Tag: FemoSeal
Vascular News’ top 10 most popular stories of October 2021
New data from a head-to-head, randomised trial comparing vascular closure devices, highlights from CX Aortic Vienna 2021 (5–7 October, broadcast) and an interview with past Society...
Head-to-head trial shows superiority of FemoSeal over ProGlide for peripheral interventions
Results of the randomised, prospective, multicentre STEP trial show that the FemoSeal vascular closure system (Terumo) is superior to the Perclose ProGlide suture-mediated closure...
Terumo completes acquisition of vascular closure business and other assets of...
Terumo has announced that it has completed its acquisition of certain assets owned by Abbott and St Jude Medical.
Terumo has acquired the Angio-Seal and...
